Analyst Ratings for Evolent Health (EVH)
EVH Rating Summary
EVH Price Target Summary
- Highest: $10.00 (Citizens)
- Lowest: $3.00 (RBC Capital)
- Average: $6.36
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.36 (+50.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Avg. $ Target:
$6.36 (+50.8%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/23/2026 | Citi | Daniel Grosslight | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.57 (4.22) |
-24.24% | Details |
| 6/30/2026 | Truist Securities | Jailendra Singh | Downgrade | Hold (Buy) |
7.00 (N/A) |
5.51 (4.22) |
-23.41% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


